Hepion Pharmaceuticals, Inc.
HEPA· OTC
HEPAHepion Pharmaceuticals, Inc.
Filed May 15, 2018 · 10-Q · 45 days after period end · 0001104659-18-033501
| Metric | Q1 2018 | Q1 2017 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$2.69M | -$7.62M | -$1.47M | — |
| EPS Diluted | -$0.27 | -$0.12 | -$0.07 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end
